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Accepted 6 January 2012A primigravid woman 38 years of age underwent amnio-
centesis at 17 weeks of gestation because of advanced
maternal age, and the result revealed a karyotype of 46,XY.
She was admitted to the hospital at 17 weeks of gestation
because of antepartum hemorrhage, placenta previa, sub-
chorionic hematoma, premature uterine contractions, and
premature rupture of the membranes following amniocentesis.
Level II ultrasonography revealed an amniotic fluid index of
6 cm, a singleton fetus with a biparietal diameter (BPD) of
3.35 cm (15.8 weeks), an abdominal circumference (AC) of
10.4 cm (16.3 weeks), a femur length (FL) of 1.63 cm (14.8
weeks), subchorionic hematoma, and a suspicion of placental
abruption. At 20 weeks of gestation, the fetal biometry was
equivalent to 18 weeks of gestation with a BPD of 4.5 cm
(19.1 weeks), an AC of 12 cm (18 weeks), an FL of 2.28 cm
(17.2 weeks), and an enlarged placenta with multiple hypo-
echoic spaces (Fig. 1). A diagnosis of placental mesenchymal
dysplasia (PMD) was made. Chorionic villus sampling (CVS)
of the bulky placenta was performed. Molecular analysis
of the sampled placental tissue revealed no uniparental
disomy (UPD) 11 and no genomic imbalance. The karyotype
of CVS was 46,XY. Repeated amniocentesis revealed coffee-
like brownish colored amniotic fluid. The karyotype of* Corresponding author. Department of Obstetrics and Gynecology, Mackay
Memorial Hospital, 92, Section 2, Chung-Shan North Road, Taipei, Taiwan.
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bridization (aCGH) analysis revealed no genomic imbalance
in the amniocytes. At 22 weeks of gestation, the multiple
hypoechoic spaces in the placenta persisted and intrauterine
growth restriction (IUGR) was evident, and the fetal biometry
was equivalent to 18 weeks of gestation. At 23 weeks of
gestation, a dead 288-g male fetus was delivered with a bulky
placenta weighing 300 g. The fetus was apparently normal.
Gross examination of the maternal surface of the placenta
showed multiple grape-like and dilated and tortuous sub-Fig. 1. Prenatal ultrasound at 20 weeks of gestation shows an enlarged placenta
with multiple hypoechoic spaces.cs & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
Fig. 2. Gross examination of the maternal surface shows multiple grape-like vesicles.
Fig. 3. Microscopic examination of the vesicles shows large dilated villi with the presence of obliterated vasculature, thrombosis and hemorrhage, and the absence
of trophoblastic proliferation. (A) Hydropic stem villi with diminished blood vessels and no trophoblastic proliferation. H & E, original magnification 20; (B)
CD34 immunohistochemical staining shows decreased blood vessels within the affected hydropic villi, 20; (C) Hydropic stem villi with a central cistern and the
surrounding normal-appearing terminal villi (H & E, 20); (D)e(F) stem villi with obliterated vasculature, thrombosis and hemorrhage; (D) H & E, 20; (E)
CD34, 20; (F) H & E, 100. H & E ¼ hematoxylin-eosin.
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large dilated villi with the presence of obliterated vasculature,
thrombosis, and hemorrhage, and the absence of trophoblastic
proliferation (Fig. 3). Postnatal genetic analysis of the dilated
villi showed no methylation abnormality, a karyotype of
46,XY, and biparental inheritance with a 1:1 paternal:maternal
dosage ratio in the microsatellite analysis of chromosomes 6,
7, 11, and 15.
PMD is a rare but benign condition that is characterized by
placentomegaly with many grape-like vesicles resembling par-
tial mole [1e6]. The incidence of PMD has been reported to be
0.02% [7]. There is a female preponderance in cases of PMD
with a female:male ratio 3.6:1 [8]. PMD is different from partial
mole by the absence of trophoblastic proliferation, the presence
of a normal-appearing fetus, a fetus with IUGR or a fetus with
overgrowth, and the diploid karyotype in majority of the cases
[4]. PMD is associated with an increased risk of IUGR and fetal
demise. In a review of 82 cases with PMD, of which 15 were
associated with Beckwith-Wiedemann syndrome (BWS), Pham
et al [9] found that, among all cases without BWS, 50% had
IUGR, 43% had intrauterine fetal demise or neonatal death, and
females represented 82% of cases.
There is an association between BWS and PMD. About
23% of the cases with PMD are associated with BWS [8]. In
such cases, there may be fetal overgrowth, omphalocele,
macroglossia, internal visceromegaly in addition to placento-
megaly and an imbalance of imprinted gene expression of the
genes CDKN1C (P57KIP2), H19, IGF-II, and KVLQT1 within
11p15.5 due to epigenetic errors and/or chromosomal abnor-
malities [10,11]. Aviram et al [12] additionally reported a case
of transient neonatal diabetes mellitus and paternal UPD 6.
Recently, androgenetic/biparental whole genome mosai-
cism was observed in cases with PMD, and this androgenetic
mosaicism may partially explain the PMD features of absence
of trophoblastic hyperplasia, association with BWS, and the
preponderance of females [10,13e19].
It has also been suggested that hypoxia or hypoperfusion can
be associated with PMD [4]. Increased angiogenesis caused by
increased expression of the vascular endothelial growth factor
(VEGF) genes may explain the pathogenesis of PMD in cases of
hypoxia or hypoperfusion [4]. X chromosome abnormalities
have also been suggested to be associated with PMD because of
abnormal expression of the VEGF-D gene on Xp22.31 [7].
The present case was a male, had a karyotype of 46,XY, and
was associated with placental previa, placental hematoma,
antepartum hemorrhage, and IUGR, but had neither UPD nor
androgenic mosaicism or genomic imbalance. The underlying
cause of PMD in this case is unknown. We speculate that
enlarged stem villi along with chorionic vessel dilation may be
a congenital malformation of the mesoderm. Our case pro-
vides evidence that PMD may present antepartum hemorrhage
and subchorionic hematoma in early gestation.
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